TC BioPharm Plots Clinical-Stage Strategy For CAR-Modified Gamma Delta T-Cells

 
• By John Davis
Cellular therapy
Interest in cell therapies for cancer is intense • Source: Shutterstock

More from R&D

More from Scrip